Diabetes Flashcards

1
Q

Define DKA

A

without insulin , glucose cannot enter muscle cells and fat is used as an alternative energy source and fat breakdown produces ketones and the ketones can cause DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Fasting BG in pregnancy

A

< 95

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

S/S of diabetes

A
polyuria
polyphagia
polydipsia
blurred vision 
fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis of prediabetes

A

FPG 100-125
2h PG 140-199
A1C 5.7-6.4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosis of diabetes

A

symptoms and random glucose > 200
FPG > 126
2h PG >200
A1C > 6.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

prevention of preeclampsia with diabetics in pregnancy

A

ASA 81

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BP goal with DM and ASCVD 10y risk of >15%

A

<130/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BP goal with DM and ASCVD 10y risk of <15%

A

<140/90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how to test for peripheral neuropathy

A

10-g monofilament

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

First line treatment for neuropathy

A

pregabalin
duloxeetine
gabatenpin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

treatment for diabetic kidney disease

A

ACEi or ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnosis for diabetic kidney disease

A

urinary albumin excretion >30mg/24 hours

urine albumin-to-creatinine ratio > 30 mg/g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ADA goal of A1C

A

<7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ADA goal of FBG

A

80-130

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADA goal of PPG

A

<180

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

First line treatment for DM with A1C >8.5% and >10%

A
  1. 5: dual therapy

10: insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

If DM and ASCVD treatment

A
GLP1 agonists
-liraglutide
-semaglutide
-exenatide
OR
SGLT2 inhibitors
-empagliflozin
-canagliflozin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

If DM and HF or CKD treatment

A
SGLT2 inhibitors
-empagliflozin
-canagliflozin
IF contraindicated use GLP1 agonists
-liraglutide
-semaglutide
-exenatide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

If DM and no ASCVD or CKD treatment

A
to minimize hypoglycemia
-DPP-4i
-GLP1-agonist
-SGLT2i
-TZD
to promote weight loss
-GLP-1 agonist
-SGLT2i
consider lower cost
-SU
-TZD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Which drugs have MOA to increase or replace insulin secretion

A

insulin
SU
meglitinides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which drugs have MOA to decrease hepatic glucose output

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which drugs have MOA to decrease glucagon which decrease glucose production

A

GLP-1 agonist
DPP-4 inhibitors
Pramlintide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which drugs have MOA to slow gastric emptying (increasing satiety)

A

GLP-1 agonists

Pramlintide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which drugs have MOA to increase glucose excretion

A

SGLT2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Which drugs increase insulin sensitivity

A

TZDs

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Janumet generic name

A

metformin/sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Contraindication to metformin

A

CrCl < 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

warning for metformin

A

lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Which clasess of drugs are insulin secretagogues

A

meglintinides

sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

List meglinitides

A

repalinide

nateglinide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Which classes of drugs cause hypoglycemia

A

metglinitinides
sulfonylureas
insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

glipizide brand name

A

glucotrol

33
Q

glimepiride brand name

A

amaryl

34
Q

glyburide brand name

A

glynase

35
Q

Name thiazolidinediones

A

pioglitazone

rosiglitazone

36
Q

contraindication for TZD

A

heart failure-b/c of edema

37
Q

List SGLT2i

A

Canagliflozin
dapagliflozin
empagliflozin

38
Q

canagliflozin brand name

A

invokana

39
Q

brand name dapagliflozin

A

farxiga

40
Q

brand name empagliflozin

A

jardiance

41
Q

Contraindication to all SGLT2i

A

CrCl < 30

42
Q

major warning for SGLT2i

A

ketoacidosis
AKI
hypotension

43
Q

major warning for canagliflozin

A

hyperkalemia

44
Q

MOA DPP4i

A

prevent the enzyme DPP-4 from breaking down incretin hormones, glucagon-like peptide 1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP) these hormones help to regulate blood glucose levels by increasing isulin release from the pancreatic beta cells and decreasing glucagon secretion

45
Q

List DPP4i

A

Sitagliptin
Saxagliptin
Linagliptin
alogliptin

46
Q

brand name for sitagliptin

A

januvia

47
Q

brand name for linagliptin

A

tradjenta

48
Q

Major warning for DPP4i

A

acute pancreatitis
arthralgia
heart failure

49
Q

SGLT2i generic name ending

A

flozin

50
Q

DPP4i generic name ending

A

gliptin

51
Q

List alpha-glucosidase inhibitors

A

acarbose

miglitol

52
Q

what dose to start basal insulin at for DM2

A

10u/d

0.1-0.2 u/kg/d

53
Q

what dose to start prandial insulin at for DM2

A

4u/d

10% of basal insulin

54
Q

GLP1 agonists generic name ending

A

tide

55
Q

list GLP1 agonists

A

exenatide
liraglutide
dulaglutide
semaglutide

56
Q

GLP1 agonists MOA

A

analogs of incretin hormone GLP-1 which increase glucose-dependent insulin secretion , decrease glucagon secretion, slows gastric emptying, improves satiety and result in weight loss

57
Q

Exenatide brand name

A

Byetta

if ER Bydureon

58
Q

Liraglutide brand name

A

Victoza

59
Q

Dulaglutide brand name

A

Trulicity

60
Q

GLP1 agnosts warning

A

thyroid carcinoma

pancreatits

61
Q

Pramlintide MOA

A

analog of amylin which is produced by pancreatic beta cells and helps control postprandial glucose by slowing gastric emptying, suppressing glucagon secretion following a meal

62
Q

Insulin MOA

A

signals liver to convert glucose to glycogen
required for glucose uptake by muscle cells
regulates fat storage, converting excess glucose to fat

63
Q

list rapid acting insulin

A

aspart
lispro
afrezza

64
Q

insulin aspart brand name

A

novolog

65
Q

insulin lispro brand name

A

humalog

66
Q

list short acting insulin

A

regular insulin

concentrated regular insulin

67
Q

list intermediate acting insulin

A

NPH

68
Q

List long acting insulin

A

determir
glargine
degludec

69
Q

brand name for insulin determir

A

levemir

70
Q

brand name for insulin glargine

A

lantus

toujeo

71
Q

brand name for insulin degludec

A

tresiba

72
Q

Key drugs that can lower blood glucose not DM meds

A

linezolid
beta blockers
quinolones

73
Q

target BG for hospitalized patients

A

140-180

74
Q

3 items to recognize DKA

A

BG > 250
ketones
anion gap

75
Q

how to recognize HHS

A

BG > 600
extreme dehydration
pH > 7.3

76
Q

which DM drugs cause weight gain

A

insulin
SU
meglitindies
TZD

77
Q

which DM drugs cause hepatotoxicity

A

TZD

alopgliptin

78
Q

which DM drugs cause UTI

A

SGLT2i